Study Unveils Insights into Gene Regulation Across the Human Genome

An international research team has made significant progress in understanding how gene expression is controlled throughout the human genome. Their study, which analyzed cis-regulatory elements (CREs)—DNA sequences that regulate gene transcription—provides new insights into cell-specific gene expression and the potential impact of mutations on health and disease.

The researchers employed a novel technology called lentivirus-based massively parallel reporter assay (lentiMPRA) to examine 680,000 candidate CREs in hepatocytes, lymphocytes, and induced pluripotent stem cells. This method allowed for simultaneous analysis of thousands of CREs by tagging them with unique DNA barcodes to track their activity.

Key findings revealed that 41.7% of analyzed CREs showed activity across the three cell types. Promoters, which initiate gene transcription, demonstrated dependence on sequence orientation but less cell-type specificity. Enhancers, which boost gene transcription, were active regardless of orientation and exhibited cell-type specificity.

The team developed machine learning models to predict CRE activity based on their experimental data. The most accurate model, MPRALegNet, closely aligned with experimental results and identified important transcription factor binding motifs, providing insights into cell-type-specific gene expression. 

Fumitaka Inoue, a co-first author of the study published in Nature, stated, "Recently, the nearly complete human genome has been sequenced, but much of its functional regions remain unknown. Our findings link DNA sequence information with its functional roles. We hope that these results will contribute to a deeper understanding of biological phenomena, including human diseases and evolution."

The researchers also placed a publicly accessible database of CRE activity on the ENCODE portal to provide valuable resources for researchers worldwide.